Partner Content Partner Content This Week's Spotlight Features GSK and Advanced Cell Diagnos... RNA Therapeutics Feb 2018
Partner Content Partner Content Dr. Dana Carroll to deliver keynote on challenges in Program... 2nd Genome Editing & Engineering Conference is back!
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.